CompletedNot Applicable

The Efficacy of Digital Educational Interventions on Parental HPV Knowledge and Attitude, and Their Children's Vaccination Rates

Indonesia374 participantsStarted 2023-07-05

Plain-language summary

The goal of this clinical trial is to examine in the parental HPV knowledge and attitude, and their children's completion rates in Indonesia. The main question\[s\] it aims to answer are: * Is the digital educational intervention in improving parent's HPV knowledge in the intervention group compared to the control group? * Is the digital educational intervention in improving parent's attitude toward HPV vaccine in the intervention group compared to the control group? * Is the digital educational intervention more effective in increasing children's HPV vaccine completion rates in the intervention group compared to the control group? Participants in intervention group will: * watch a 8 minutes video in front of class at once. * after video education intervention, in 2 weeks, participants received 2 reminder messages before first and second vaccination event, respectively. Participants in control group will: • Receive usual announcement regarding vaccine by staff

Who can participate

Age range

17 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Parents over 17 years old * Parents Parents who have daughters of 5-6th level in elementary school * Parents live with their children in one house * Parents have a mobile phone with WhatsApp application capabilities * Parents who have their daughters have been enrolled in School-Based Immunization Program database * Parents able to communicate fluently in Bahasa Indonesia * Parents agree to review their child's medical record of vaccination Exclusion Criteria: * Parents have diagnosed with mental, visual, and hearing impairment/problems diagnosed by doctors * Parents whose children have been HPV vaccinated * Parents whose children are over 14 years old * Children who have a history of allergies and/or side effects in previous vaccination programs

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Human Papillomavirus Knowledge Scale (HPV-KS)

Timeframe: measured at pre-test/baseline (before the 8-minutes video) and post-test (immediately after watching the 8-minutes video).

Attitude towards HPV vaccine scale by Carolina HPV Immunization Attitudes and Beliefs Scale (CHIAS)

Timeframe: measured at pre-test/baseline (before the 8-minutes video) and post-test (immediately after watching the 8-minutes video).

Vaccine completion rate

Timeframe: The evaluation was conducted twice, at week 2 post video intervention or at first vaccination event and 6 months later at second vaccination event.

Trial details

NCT IDNCT06341738

SponsorKaohsiung Medical University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-02-01

View on ClinicalTrials.gov More Health Services Research trials

Plain-language summary

Who can participate

Age range

17 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Human Papillomavirus Knowledge Scale (HPV-KS)

Timeframe: measured at pre-test/baseline (before the 8-minutes video) and post-test (immediately after watching the 8-minutes video).

Attitude towards HPV vaccine scale by Carolina HPV Immunization Attitudes and Beliefs Scale (CHIAS)

Timeframe: measured at pre-test/baseline (before the 8-minutes video) and post-test (immediately after watching the 8-minutes video).

Vaccine completion rate

Timeframe: The evaluation was conducted twice, at week 2 post video intervention or at first vaccination event and 6 months later at second vaccination event.